Zhang, Xingnan
Hu, Chenhao
Sun, Shengqiao
Guo, Chao
Bu, Yakun
Wang, Zicong
Liu, Zewei
Zhang, Xiaoli
Li, Dezhi
Liu, Song
Funding for this research was provided by:
National Natural Science Foundation of China (82171364, 82171364, 82171364)
Platform Construction of Basic Research and Clinical Translation of Nervous System Injury (PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006, PXM2021_026280_000006)
Article History
Received: 16 June 2024
Accepted: 28 October 2024
First Online: 31 October 2024
Declarations
:
: The authors declare no competing interests.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
: This study was approved by the ethical committee of the National Cancer Center, and all patients in this study provided written informed consent (2004050). The use of animal models was approved by Beijing Neurosurgical Institute Ethics Committee of Capital Medical University (BNI202304002).All experiments were performed in accordance with relevant guidelines and regulations. Other data provided in the supplementary information file.
: No potentially identifiable human images or data are presented in this study.